Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: Feasibility in Asian population
- 1 May 2011
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 29 (3) , 275-279
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USABMC Cancer, 2005
- VALUE OF PROSTATE-SPECIFIC ANTIGEN IN THE STAGING OF TAIWANESE PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCERArchives of Andrology, 2003
- Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma?Cancer, 2002
- Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: evaluation of mass screening populationsUrology, 2000
- The Value of a Baseline Bone Scan in Patients With Newly Diagnosed Prostate CancerClinical Nuclear Medicine, 1999
- Dissociation of bone formation markers in bone metastasis of prostate cancerBritish Journal of Cancer, 1997
- Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancerUrology, 1996
- USING PSA TO ELIMINATE THE STAGING RADIONUCLIDE BONE SCANUrologic Clinics of North America, 1993
- Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical ParametersJournal of Urology, 1991